TABLE 1
FROM:
Phosphodiesterase 11: a brief review of structure, expression and function
A Makhlouf, A Kshirsagar and C Niederberger
BACK TO ARTICLETable 1. Summary of PDE family characteristics1, 7, 8, 9
|
PDE family |
Genes (if multigene) | Substrate | Inhibitors, Ki or (IC 50) | Regulation | Tissue expression |
|---|---|---|---|---|---|
| 1 | PDE1A | cAMP>cGMP | Vinpocetine (14
M)
| (+)Ca2+/CAM | 1A: Thyroid, testis, brain |
| PDE1B | cAMP>cGMP | Zaprinast (6
M) | (-)PKA, CamKII | 1B: Brain, lymphocytes | |
| PDE1C | cAMP=cGMP | Sildenafil (0.35
M) | 1C: Blood vessels, testis | ||
| 2 | cGMP cAMP | EHNA (1
M)
| (+)cGMP, PKC | Brain, heart, platelets, liver, thymocytes | |
Bay 60-7550 (0.047
M) | (+/-)N-terminal-targeting domain | ||||
| 3 | PDE3A | cAMP>cGMP | Cilostamide (0.020
M)
| (+)PKA, PKB | 3A: Heart, blood vessels |
| PDE3B | Milrinone (0.150
M)
| (-)cGMP | 3B: Adipocytes, hepatocytes, lymphocytes | ||
Zardaverine (0.5–2
M) | (+/-)N-terminal-targeting domain | ||||
| 4 | PDE4A | cAMP | Rolipram (1
M)
| (+)PKA, ERK, phosphatidic acid | 4A: Lung, immune cells, brain, blood vessels |
| PDE4B | Roflumilast (0.8 nM) | (-)ERK, caspases | |||
| PDE4C | Cilomilast (120 nM) | (+/-)N-terminal-targeting domains | |||
| PDE4D | Zardaverine (0.8–4
M) | ||||
| 5 | cGMP | Zaprinast (0.130
M)
| (+)cGMP, PKG, PKA | Smooth muscle, platelets, Purkinje cells, gastro-intestinal epithelium, pulmonary endothelium | |
Sildenafil (0.10
M)
| (-)Caspases | ||||
Vardenafil (0.001
M)
| |||||
Tadalafil (0.010
M)
| |||||
| 6 | PDE6A | cGMP | Zaprinast (0.400
M)
| (+)Transducin | Retinal photoreceptors |
| PDE6B | Dipyridamole (0.125
M)
| (-)cGMP, gamma and delta subunits | |||
| PDE6C | Sildenafil (0.050
M)
| ||||
Vardenafil (0.011
M) | |||||
Tadalafil (2
M) | |||||
| 7 | PDE7A | cAMP | IBMX (4
M)
| (+/-)PKA | Brain, lymphocytes, kidney |
| PDE7B | Dipyridamole (0.6
M)
| ||||
| 8 | PDE8A | cAMP | Dipyridamole (9
M)
| PAS domain | Thyroid |
| PDE8B | |||||
| 9 | cGMP | Zaprinast (35
M)
| Unknown | Kidney | |
| 10 | cGMP>cAMP | Dipyridamole (1
M)
| (-)cAMP | Testis, brain | |
Zaprinast (22
M) | |||||
| 11 | cAMP and cGMP | Zaprinast (12
M)
| Unknown | Skeletal muscle, prostate, testis, corpus cavernosum, heart (but see text and Table 3) | |
Dipyridamole (0.4
M)
|
CAM=calmodulin c; ERK=extracellular signal-regulated protein kinase; PAS=periodic acid-Schiff stain; PDE=phosphodiesterase; PKA=protein kinase A; PKC=protein kinase A; PKG=protein kinase G.
Only some of the most commonly reported inhibitors for each PDE are listed. Tissue expression is representative of most reports and is not necessarily exhaustive.

cAMP